| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |